NIAID Clinical Trial Implementation Cooperative Agreement
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the NIAID Clinical Trial Implementation Cooperative Agreements. This program encourages cooperative agreement applications for implementation of investigator-initiated, milestone driven, high-risk cl
| Agency | National Institutes of Health |
|---|---|
| Status | Forecasted |
| Opportunity number | FOR-AI-27-007 |
| Posted date | 06/27/2025 |
| Assistance Listing (CFDA) | 93.855 |
| Description | The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the NIAID Clinical Trial Implementation Cooperative Agreements. This program encourages cooperative agreement applications for implementation of investigator-initiated, milestone driven, high-risk clinical trials including mechanistic studies associated with these clinical trials. Due to this focus, the program encompasses both basic and clinical research. This program includes support for the conduct, completion, and analysis of the clinical trial. Additional activities supported are related to the conduct of the clinical trial including training of study personnel; enrollment and recruitment of study subjects; data collection, clinical data management and quality contr |
| Agency contact | cynthia.delafuente@nih.gov |
| Official listing | https://www.grants.gov/search-results-detail/359859 |